Skip to content
Menu

Entrada Therapeutics, Inc. TRDA

Full chart Compare
Set alert

Price alert · TRDA

All alert types
5.25 USD +0.29 (+5.89%)

As ofNov 18, 2026, 1:33 PM EST

4.81 Day range 5.50
4.11 52-week range 16.45
YTD
-48.91%
1 year
-40.45%

TRDA free cash flow history

Free cash flow is operating cash flow minus capital expenditure outflow. It can be negative; it is not the same as earnings.

-129,553,000 USD

FY 2025 · Period ended

Coverage: complete. Values in USD; not inflation adjusted.

Reporting currency is USD by the source’s USD conversion factor of 1; the source does not name the currency.

Capital expenditure here is net of asset disposals, so free cash flow can be higher than a figure that subtracts gross purchases.

Scroll the table to see all values →

Free cash flow · annual · USD
Fiscal periodPeriod endFree cash flowYoY changeYoY %
FY 20252025-12-31-129,553,000-84,838,000Not meaningful
FY 20242024-12-31-44,715,000-178,904,000-133.32%
FY 20232023-12-31134,189,000230,862,000Not meaningful
FY 20222022-12-31-96,673,000-41,231,000Not meaningful
FY 20212021-12-31-55,442,000-27,554,000Not meaningful
FY 20202020-12-31-27,888,000-16,457,000Not meaningful
FY 20192019-12-31-11,431,000Not availableNot available

Percentage growth is shown only when the same fiscal period one year earlier has a positive value. Missing periods are not estimated.

Company-reported financial statements. Retrieved 2026-11-09T07:00:38.000Z. Retrieval time is not a report date.

Open full statements

Use Add to watchlist above to save this stock.